These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29642773)

  • 1. DCE-MRI-Derived Volume Transfer Constant (K
    Ye ZM; Dai SJ; Yan FQ; Wang L; Fang J; Fu ZF; Wang YZ
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618765254. PubMed ID: 29642773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of short- and long-term efficacy of chemoradiotherapy for advanced cervical cancer using HSP70 protein combined with multimodal MRI.
    Qi YX; Liu K; Yin J; Li L
    J Cell Biochem; 2018 Apr; 119(4):3017-3029. PubMed ID: 29023986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography.
    Huang YS; Chen JL; Chen JY; Lee YF; Huang JY; Kuo SH; Yen RF; Chang YC
    Strahlenther Onkol; 2019 Aug; 195(8):707-718. PubMed ID: 30610356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy.
    Onal C; Erbay G; Guler OC
    J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence.
    Nakamura K; Joja I; Nagasaka T; Fukushima C; Kusumoto T; Seki N; Hongo A; Kodama J; Hiramatsu Y
    Gynecol Oncol; 2012 Dec; 127(3):478-83. PubMed ID: 22892362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer.
    Heethuis SE; Goense L; van Rossum PSN; Borggreve AS; Mook S; Voncken FEM; Bartels-Rutten A; Aleman BMP; van Hillegersberg R; Ruurda JP; Meijer GJ; Lagendijk JJW; van Lier ALHMW
    Acta Oncol; 2018 Sep; 57(9):1201-1208. PubMed ID: 29781342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of b-values in diffusion-weighted imaging for esophageal cancer: Measuring the longitudinal length of gross tumor volume and evaluating chemoradiotherapeutic efficacy.
    Liu G; Yang Z; Li T; Yang L; Zheng X; Cai L
    J Cancer Res Ther; 2017; 13(5):748-755. PubMed ID: 29237898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Ng SH; Lin CY; Chan SC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Huang SF; Lin YC; Wang JJ
    PLoS One; 2013; 8(8):e72230. PubMed ID: 23951300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of diffusion weighted and dynamic contrast-enhanced MRI in loco-regionally advanced head and neck cancer treated with concomitant chemoradiotherapy.
    Garbajs M; Strojan P; Surlan-Popovic K
    Radiol Oncol; 2019 Mar; 53(1):39-48. PubMed ID: 30840595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined dynamic contrast enhanced MRI parameter with clinical factors predict the survival of concurrent chemo-radiotherapy in patients with 2018 FIGO IIICr stage cervical cancer.
    Qin F; Pang H; Ma J; Zhao M; Jiang X; Tong R; Yu T; Luo Y; Dong Y
    Eur J Radiol; 2021 Aug; 141():109787. PubMed ID: 34051683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of DCE-MRI and DWI in Predicting the Treatment Effect of Concurrent Chemoradiotherapy in Esophageal Carcinoma.
    Liu C; Sun R; Wang J; Ning F; Wang Z; Luo J; Chen S; Yuan S
    Biomed Res Int; 2020; 2020():2576563. PubMed ID: 32626736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of preoperative magnetic resonance imaging features and diagnostic effectiveness of grades II and III intracranial solitary fibroma.
    Ran Y; Wang X; Zhang Y; Chen R; Liu C; Ran Y; Wang W; Ma X; Wang M; Cheng J
    Eur J Med Res; 2024 Jul; 29(1):377. PubMed ID: 39030639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative quantitative dynamic contrast-enhanced MRI and diffusion-weighted imaging predict aggressive disease in endometrial cancer.
    Fasmer KE; Bjørnerud A; Ytre-Hauge S; Grüner R; Tangen IL; Werner HM; Bjørge L; Salvesen ØO; Trovik J; Krakstad C; Haldorsen IS
    Acta Radiol; 2018 Aug; 59(8):1010-1017. PubMed ID: 29137496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion Parameters in Dynamic Contrast-enhanced MRI and Apparent Diffusion Coefficient Value in Diffusion-weighted MRI:: Association with Prognostic Factors in Breast Cancer.
    Lee HS; Kim SH; Kang BJ; Baek JE; Song BJ
    Acad Radiol; 2016 Apr; 23(4):446-56. PubMed ID: 26852247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted imaging in evaluating the efficacy of concurrent chemoradiotherapy in the treatment of non-small cell lung cancer.
    Xu HD; Zhang YQ; Shen WY; Mao ZC
    Tumori; 2018 Jun; 104(3):188-195. PubMed ID: 28362059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between functional imaging markers derived from diffusion-weighted MRI and 18F-FDG PET/CT in esophageal cancer.
    Goense L; Heethuis SE; van Rossum PSN; Voncken FEM; Lagendijk JJW; Lam MGEH; Terhaard CH; van Hillegersberg R; Ruurda JP; Mook S; van Lier ALHMW; Lin SH; Meijer GJ
    Nucl Med Commun; 2018 Jan; 39(1):60-67. PubMed ID: 29023336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.